Safety and Efficacy of IBI188 With Azacitidine in Subjects With Newly Diagnosed Higher Risk MDS
Clinical trial NCT04485065 · SUSPENDED
Trial details
- NCT number
- NCT04485065
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2023-12-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.